content top

Safety and Efficacy of Intravitreal Preservative-free Triamcinolone for ME Secondary to Diabetes or Retinal Vein Occlusion

Purpose: To evaluate the efficacy and safety of preservative-free triamcinolone acetonide injectable suspension (Taioftal) for the treatment of macular edema secondary to diabetes or retinal vein occlusion. Design, Setting & Participants: From January 2015 to December 2015, at Ospedale Maggiore of Bologna, a retrospective study was conducted on patients suffering from macular edema secondary to diabetes or retinal vein occlusion....

Read More

Central Retinal Vein Occlusion: What`s New ?

Despite numerous studies describing predominantly its clinical course, many aspects of central retinal vein occlusion (CRVO) remain unclear. Hypotheses on the pathogenesis of CSCR have ranged from a basic alteration in the blood stream to an involvement of the blood vessel wall. We reviewed the different therapeutic approaches, including laser induced chorioretinal anastomosis (LICRA), vitrectomy (PPV) and intravitreal treatment (IVT)....

Read More

Retinal Vein Occlusion: Can it be Due to Vasculitis?

Retinal Vein Occlusion is the one of the most important causes for vision loss due to retinal conditions. Most of the time it is due to some associated systemic factors. Vascultis should be suspected in younger age groups with vein occlusions especially where no contributory systemic factors are present. Vasculitis as a disease presents with varied types of manifestations. Retinal vasculitis usually occurs in young patients with the...

Read More

Efficacy of Three Monthly Injections of Ranibizumab for ME Secondary to BRVO

11 dec 2013 … purchase viagra online buy fluoxetine 10 tulsa usa free viagra sample pills cheap fluoxetine in the uk fluoxetine by mail order fluoxetine online without prescription in canada and save money! online buy viagra. affordable viagra – Kateryna Chui_SCIENTIFIC POSTER 2015 Purpose: To assess the efficacy of the three monthly injections of ranibizumab for the treatment of macular oedema (MO) secondary to branch retinal...

Read More

Clinical Features According to the Diurnal Blood Pressure Variation in BRVO

Hyunwoong Kim_SCIENTIFIC POSTER 2015 Objectives: To investigate clinical features according to the diurnal blood pressure variation in branch retinal vein occlusion (BRVO) using 24-hour ambulatory blood pressure monitoring (24-hour ABPM). Methods: 24-hour ABPM was performed in patients with BRVO. The non-dipper was defined as a nocturnal systolic blood pressure (SBP) decrease less than 10%. Retinal vein occlusion site in fluorescein...

Read More

Combined Ranibizumab + Laser Photocoagulation for ME Secondary to BRVO

SCIENTIFIC POSTER_Kateryna Chui baclofen no rx no rx baclofen cod delivery oral baclofen baclofen iv pump order baclofen purchase prednisolone online – safe pharmacy. buy prednisolone online no prescription . buy without a prescription prednisolone 5mg . prednisolone  overnight cod where to buy baclofen rx saturday shipping nebraska prednisone cost walmart prednisone cost walmart buy prednisone online Purpose: To investigate...

Read More

Treating RVO with a Sequential Treatment

Purpose: To evaluate the efficacy and safety of combination therapy with intravitreal ranibizumab followed by dexamethasone implant as compared to dexamethasone implant alone in treating macular edema (ME) due to retinal vein occlusions (RVO). Methods: Retrospective, comparative study. Results: 18 patients had intravitreal ranibizumab followed by dexamethasone implant within 6 weeks of injection (group 1), 19 patients had dexamethasone...

Read More

Patients Demographics, Ocular Co-pathology & Results for RVO with ME Treated with Ozurdex

The purpose of this work is to describe patients’ demographics, existing ocular co-pathology and treatment procedures for patients treated with Ozurdex for macular oedema due to branch and central retinal vein occlusion in the UK National Health Service (NHS). A multicenter national database study of prospectively collected anonymized data within an electronic medical record system (Medisoft). Data from participating 15 NHS centres across...

Read More

Early vs Late Treatment of ME Due to BRVO with Either Ranibizumab or Bevacizumab

SCIENTIFIC POSTER_Sezin Ozdogan Erkul_1 In this study we wanted to compare efficacy and safety of bevacizumab and ranibizumab in treatment of macular edema due to branch retinal vein occlusion depending on the duration of macular edema. An institutional review board approved retrospective survey was done among 58 eyes of 57 patients having macular edema due to branch retinal vein occlusion. Patients were grouped according to the initial...

Read More

Dexamethasone Implant vs Ranibizumab for RVO with ME : Efficacy Comparison

SCIENTIFIC POSTER_Chi Fung Ernie Lo Background: To evaluate the efficiency of Dexamethasone implants to Ranibizumab injections in macular edema secondary to retinal vein occlusion (RVO) in clinical setting. Design: This is a retrospective comparative cohort study Participants: 44 eyes of 44 newly diagnosed patients with macular edema secondary to either branch retinal vein occlusion or central retinal vein occlusion. Included patient...

Read More

Unusual Ocular Pretrombotic Syndrome

RETINA PHOTO_Javier Placeres Images showing retinal hemorrhages at different levels (three of them in the subhyaloid space, many of them in the intraretinal space and combined hemorrhages in areas of posterior vitreous detachment).

Read More

Dexamethasone Implant in a Pregnant Woman for the Treatment of ME in CRVO

Poster Jesus Zarallo Gallardo Introduction: There are several retinal diseases that may worsen or alter during pregnancy as a result of hematologic, hormonal, metabolic, cardiovascular, and immunologic changes. Although normal pregnancy and its hypercoagulable state may induce retinal vein occlusion, hereditary or acquired changes in hemostatic factors increase the risk of thromboembolic events. The risk of venous thromboembolism in...

Read More

The Availability of 24-hour Ambulatory Blood Pressure Monitoring in the BRVO

Poster Il Han Yun Purpose: Hypertension is a major risk factor of retinal vascular occlusion. Generally, blood pressure (BP) has a tendency of fluctuation increased with activity and decreased at night or rest. Especially, non-dipper status is thought to be of clinical and prognostic relevance to target organ damage (TOD) in many studies. So we took part in a measure the 24-hour ambulatory blood pressure monitoring (24hour ABPM) in...

Read More

Comparison of the Axial Length Measurement by Partial Interferometry and Sonography in the Retinal Vein Occlusion

Poster Jung Yeul Kim Purpose: To investigate the axial length of the retinal vein occlusion using contact A-scan sonography and partial interferometry. Participants: The Nineteen patients diagnosed of acute retinal vein occlusion with macular edema and the 24 patients diagnosed of chronic retinal vein occlusion without macular edema. Methods: The central macular thickness was measured by optical coherence tomography. The axial length was...

Read More

ILM Peeling in RVO

The author initiated the ILM Peeling as a treatment of BRVO and CRVO in February 2000 and is continuing this technique due to the quality of the results: 4,15 LogMAR lines of average improvement 69% of patients improved their visual acuity Only 6,4% of patients had a decreased visual acuity Reduction of the edema (by OCT measurement) of 200 µ We will present, this year, the results after long-term follow-up (more than 5 years) in order...

Read More

ILM Peeling in RVO

The study is on 150 patients with a follow-up of at least one year. The aim of the study is to show the interest / advantage of ILM Peeling in RVO considering functional recovery, and to compare these results to other existing techniques. The study shows significantly the superiority of ILM Peeling in the quality of functional results, confirmed by the stabilization of the OCT measured macular thickness, but mostly, as opposed to other...

Read More

Surgery Associated with Intravitreal Anti-VEGF Agents in CRVO. A More Rational Approach?

Central retinal vein occlusion is a multi-factorial event. Like any venous thrombosis, one of the key components in play is stenosis of the vessel. In the eye, this stenosis generally originates from the vein being compressed by a sclerotic artery in a non-expandable space such as the optic nerve at the level of lamina cribrosa. Resection of the lamina cribrosa should therefore result in proper reperfusion of the central retinal vein and...

Read More

Medical Limits in Macular Edema After RVO

Purpose: To compare the quality of life of different patients treated for macular edema: – Some are treated using topics injections (triamcinolone, lucentis) – Some are treated using a surgical procedure (ILM peeling combined or not to triamcinolone injection) Material and Methods: It is very important to know how the different patients organise their live between the different control, OCT, angiographes, and the normal live...

Read More

Evaluating Adjunctive Surgery to Ozurdex for the Treatment Macular Edema Following RVO

Ozurdex®, a dexamethasone (DEX) intravitreal implant, has been shown in randomized controlled trials to reduce macular edema and improve visual acuity in patients with either branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). However, repeated injections are usually necessary, particularly for CRVO patients. And the long-term adverse events, including the incidence of cataract and glaucoma, are still...

Read More

Combined Therapy of Macular Edema Following RVO

Advantages: Thrombosis of central retinal vein (CRV) and its branches is the second most prevalent vascular pathology after diabetic retinopathy, which results in abrupt decrease in visual acuity and is accompanied by macular edema. Use of pharmacological inhibitors of vascular endothelial growth factor (Bevacizumab, Ranibizumab and Pegantacib) has been a promising direction in treatment of this pathology, since elevated VEGF levels is...

Read More

Combined Therapy for Recurrent Macular Edema Following RVO

Purpose: To report 4 cases of recurrence of macular edema (ME) after treatment with dexamethasone intravitreal implant 0.7 mg (Ozurdex; Allergan, Inc, Irvine, CA) in patients with ME following branch retinal vein occlusion (BRVO) or central retinal vein occlusion (CRVO). Methods: Retrospective case-report. Results: 4 subjects suffering from ME following both BRVO (n=3) and CRVO (n=1) were treated with dexamethasone intravitreal implant...

Read More

3 Bevacizumab vs 2 Triamcinolone Injections in Recent BRVO

Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more efficacious than repeated intravitreal injections of triamcinolone (IVT) in the treatment of macular edema in acute branch retinal vein occlusion (BRVO).

Read More

3 Bevacizumab vs 2 Triamcinolone Injections in Recent CRVO

Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more efficacious than repeated intravitreal injections of triamcinolone (IVT) in the treatment of macular edema in eyes with acute central retinal vein occlusion (CRVO). Methods: In a randomized clinical trial, 110 eyes with recent onset (less than 12 weeks) CRVO were included. Participants were randomly assigned to two treatment groups: IVB group (56 eyes), patients...

Read More

Ischemic Changes After Intravitreal Injections for Treatment of ME with CRVO

Advantages: To investigate the ischemic changes after intravitreal injection for treatment of ME with CRVO. Methods:   55 patients treated with anti-VEGF for ME with CRVO were included. Take home message: Intravitreal injection for ME with CRVO could induce ischemic changes in some cases. So these possibilities have to be notified to patients and close follow-up is...

Read More

Comparison of Triamcinolone vs Bevacizumab Combined with Grid Laser in ME Due to BRVO

Advantages: To compare the effectiveness of intravitreal triamcinolone and bevacizumab injections combined with grid laser photocoagulation for macular edema due to branch retinal vein occlusion. Methods: Retrospective, comparative, interventional clinical study. 37 patients with macular edema due to branch retinal vein occlusion treated with intravitreal triamcinolone acetonide injection combined with grid laser photocoagulation and 18...

Read More

Early Treatment of ME Secondary to CRVO with Intravitreal Bevacizumab

Advantages: To evaluate visual and anatomical outcomes of macular edema (ME) secondary to central retinal vein occlusion (CRVO) after early onset treatment with intravitreal injections of bevacizumab (IVB). Methods: Ten consecutive eyes with ME secondary to nonischemic CRVO were included in this retrospective study. All patients had fundus fluorescein angiography (FFA) and optical coherence tomography at presentation. All patients were...

Read More

Treatment of Macular Edema Secondary to Central Retinal Vein Occlusion: Comparison of Pars Plana Vitrectomy with Internal Limiting Membrane Peeling and Intravitreal Bevacizumab Injection

Hande Etus, Levent Karabas, Yusuf Çaglar (Kocaeli, Turkey) Advantages: To compare anatomic and functional results in patients with macular edema in central retinal vein occlusion (CRVO) treated with pars plana vitrectomy (PPV) with internal limiting membrane (ILM) peeling and intravitreal bevacizumab injection treatment (IVBT). Methods: A total of 29 patients were examined retrospective. PPV with ILM peeling was performed in Group A...

Read More

Bevacizumab Therapy for Branch Retinal Vein Occlusion Associated with Normal Tension Glaucoma

Sung Pyo Park (Seoul, South Korea), Jae Kyoun Ahn (Gwangiu, South Korea) Purpose: To evaluate the therapeutic efficacy of intravitreal bevacizumab (IVB) in the treatment of branch retinal vein occlusion (BRVO) in eyes with normal tension glaucoma (NTG). Methods: We included sixteen NTG eyes and 48 age- and sex-matched eyes without NTG that had received IVB for BRVO with more than 6 months’ follow-up. The main outcome measures were...

Read More

Why Use the Pascal Laser to Treat Retinal Vascular Ischemic Pathologies and Macular Edemas?

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Catherine Favard (Paris, France) Advantages: The Pattern Scanning Laser (Pascal) is a semi-automatic photocoagulator using short pulses of 10 to 20 milliseconds applied in square (2X2 to 5X5 impacts) or grid (14 to 56 impacts) patterns. Methods: Between March 2008 and May 2010, 27 eyes: 15 Ischemic diabetic retinopathies (DR) and 12...

Read More

Radial Optic Neurotomy Revisited

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Giampaolo Gini, Giorgio La Rocca (Florence, Italy) Advantages: RON offers dramatically better anatomic and functional results as compared to non-surgical procedures provided that the following criteria are used: – proper patient selection – early intervention – ILM peeling. Methods: Early vitrectomy associated with...

Read More

Combined Treatment of CME after Branch Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Ivan Fiser, Martina Rubesova (Prague, Czech Republic) Advantages: In most cases of persisting CME after BRVO we use vitrectomy with ILM peeling which has a good effect in more than 60 % of eyes but. In some patients we start with Avastin that brings a repeated benefit but later recurrences of CME happen. Laser coagulation in edematous...

Read More

Combined Treatment of CME after Central Retinal Vein Occlusion

Ivan Fiser, Martina Rubesova (Prague, Czech Republic) Advantages: CME after CRVO is a typical case where it is very difficult to define which treatment is best to start with. Triamcinolone can be helpful (which was shown in a recent study) but a recurrence can happen. Avastin also has a temporary effect. ILM peeling can be beneficial, too, but we also see recurrences of CME after it. Laser treatment of edematous retina is difficult. We...

Read More

Central Retinal Vein Occlusion / Branch Retinal Vein Occlusion: It is More Brilliant to Peel the ILM

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Didier Ducournau (Nantes, France) Last year, during the 2009 EVRS congress, we presented the results of ILM removal on 236 patients presented a macular edema after BRVO (82) and CRVO 154); more than one year after operation, the obtained improvement (in LorMAR lines) was superior to 5 lines i.e. twice as much than after repeated...

Read More

ILM Peeling in Branch Retinal Vein Occlusion & Central Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Jean-Paul Amar (Cannes, France) The author made a study on 130 cases over 3 years. The results confirmed those presented last year by Didier Ducournau. The removal of the ILM demonstrates a long-term improvement of visual acuity and a nearly total disappearance of neovascular glaucoma. The importance of the improvement is higher than the...

Read More

Avastin Laser Combination Equivalent to ILM Peeling in Central Retinal Vein Occlusion: A Review of Cases

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Theodoros Potamitis, Yianna Antoniou (Limassol, Cyprus) Advantages: The use of Avastin has revolutionized the management of many retinal vasculopathies over the past few years and when its use leads to the avoidance of surgery the advantages to the patient are obvious. Methods: Patients over a five-year period with CRVO treated by both...

Read More

Three-Intravitreal Bevacizumab vs Two-Intravitreal Triamcinolone Injections in Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Alireza Ramezani, Morteza Entezari, Siamak Moradian, Hamed Esfandiari, Babak Dehsarvi, Masoud Soheilian, Hamid Ahmadieh, Mehdi Yaseri (Tehran, Iran) Advantages: Repeated intravitreal injections of bevacizumab (IVB) are more effective than repeated intravitreal injections of triamcinolone (IVT) in acute retinal vein occlusion...

Read More

Intravitreal Bevacizumab vs Sham Treatment in Acute Branch Retinal Vein Occlusion with Macular Edema: Short Term Results (Report 1)

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Siamak Moradian, Hooshang Faghihi, Babak Sadeghi, Niloofar Piri, Hamid Ahmadieh, Masoud Soheilian, Mohammad Hossein Dehghan, Mohsen Azarmina, Mohammad Riazi Esfahani (Tehran, Iran) Advantages: To compare the visual and anatomical (central macular thickness; CMT) outcomes of intravitreal bevacizumab (IVB) injections relative to sham...

Read More

Retrospective Analysis of 16 Patients with Central Retinal Vein Obstruction

Hülya Güngel, Ozen Osmanbasoglu, Ebru Demet Aygit (Istanbul, Turkey) Advantages: To evaluate the clinical findings and treatment outcomes in patients with central retinal vein obstruction (CRVO). Methods: 16 patients’ data that were followed more than 6 months were evaluated. Based on the angiographic findings patients were grouped as ischemic and non-ischemic CRVO. Visual acuity, OCT findings and treatment modalities were...

Read More

Intravitreal Injection of Bevacizumab for the Treatment of Macular Edema Secondary to Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Salim Ben Yahia, Riadh Messaoud, Imen Chtioui, Rim Kahloun, Sonia Zaouali, Moncef Khairallah (Monastir, Tunisia) Advantages: To manage macular edema secondary to retinal vein occlusion with intravitreal injection of bevacizumab. Methods: Thirty eyes of 30 patients with macular edema secondary to retinal vein occlusion (central retinal...

Read More

Examination of the Relation Between Clinic, Fluorescein Angiographic Findings and Ophthalmodynamometric Measurements in Patients with Central Retinal Vein Obstruction

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Hülya Güngel (Istanbul, Turkey) Advantages: To examine the relation between clinic, fluorescein angiographic findings and ophthalmodynamometric measurements in patients with central retinal vein obstruction. Methods: Routine ophthalmologic examination, fluorescein angiography and ophthalmodynometry was performed in 28 subjects. H.K....

Read More

Intravitreal Growth Factors in Central Retinal Vein Occlusion and Branch Retinal Vein Occlusion

http://www.evrs.eu/medias/2010/congress/Branch-Retinal-Vein-Occlusion-Central-Retinal-Vein-Occlusion.flv Michael Koss, M. Pfister, F. Rothweiler, M.  Michaelis, J.  Cinati, Pankaj Singh, Frank Koch (Frankfurt am Main, Germany) Advantages: To determine the levels of intravitreal VEGF A, monocytic adhesion protein = MCP, and IL-6 levels in retinal vein obstruction over a clinical observation time. Methods: Twelve patients with central...

Read More

Intravitreal Triamcinolone and Bevacizumab Injection for Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

Kubilhan Elmas, Özgür Bilen, Ali Altýnsoy (Ankara, Turkey) Purpose: To evaluate the efficacy of intravitreal triamcinolone injection in eyes with macular edema due to branch retinal vein occlusion (BRVO) over a 1-year period. Methods: The authors performed a retrospective chart review of 18 eyes of 18 patients (mean age 71 years) who underwent intravitreal injections with 2 mg triamcinolone acetonide and 1,25 mg bevacizumab for macular...

Read More

Intravitreal Triamcinolone Acetonide for Macular Edema Owing to Retinal Vein Occlusion

Ozgür Bilen, Kubilhan Elmas, Ali Altýnsoy (Ankara, Turkey) Purpose: To assess the long-term safety and efficacy of intravitreal triamcinolone acetonide injection in the management of macular edema caused by branch retinal vein occlusion. Methods: This retrospective case series included 11 patients (11 eyes) with retinal vein occlusion and macular edema. They received an intravitreal injection of 4 mg triamcinolone acetonide. Follow-up...

Read More

Retinal Vein Occlusion

Slawomir Cisiecki (Lodz, Poland), Mario Facino (Genoa, Italy), Manal Bouhaimed (Kuwait), Michael Koss (Frankfurt / Main, Germany) Diagnosis of  RVO (ancilliary test), imaging (FAG, OCT), pathophysilogy, potential laboratory work up – Michael Koss Medical therapy (new drugs, laser treatment) – Slawomir Cisiecki Surgical therapy (state of art, ILM peeling vs vitrectomy , sheatotomy, neurotomy as a history? – possible...

Read More

ILM Peeling in CME Secondary to RVO

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Author: Didier Ducournau, Nantes, France As I already previously presented in a former EVRS Congress, removing the ILM induces a retinal response with a gliosis of the Muller Cells. This filling of microfibers of GFAP has different effects:  Fight against the blood retinal barrier break down and then against the edema Maintaining the retinal thickness re-establishing a...

Read More

Revisiting Retinal Vein Occlusions

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Author: Robert Nutt, Johannesburg, South Africa Advantages: CRVO has an incidence of 01.- 0.4% in individuals over the age of forty .  BRVO has an incidence of 0.4 – 0.9%. These numbers differ with age. The nature of these occlusions is such that they are not well anticipated. The result is that once present, the management becomes that of managing the complications....

Read More

Visual Outcomes in Five Different Approaches for Treatment of Central Retinal Vein Occlusion

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Masoud Soheilian, Alireza Ramezani, Ali Tavallali, Mohammad R. Mohebbi, Gholam A. Peyman, Tehran, Iran Advantages: Four treatment methods for central retinal vein occlusion (CRVO) were compared with its natural course. Methods: In this partially prospective, comparative, interventional case series on 63 eyes with CRVO, five approaches were compared: intravitreal...

Read More

Our Current Multitasking Approach to BRVO and CRVO

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Vincenzo Ferrara, G. Macrì, Vito Belloli, Arona, Italy Advantages: Macular dysfunction occurs in almost all eyes with central retinal vein occlusion (CRVO) and branch retinal vein occlusions (BRVO) presenting a persistent macular edema, nonperfusion of the parafoveal capillaries, and damage to the retinal pigment epithelium caused by extensive hemorrhage. Actually...

Read More

Bevacizumab for Retinal Vein Occlusions

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Ron A. Adelman, M.K. George, New Haven, CT, USA Advantages: Improvement in visual acuity and macular edema in patients with retinal vein occlusions. Methods: 19 patients with retinal vein occlusions were included in the study. Patients received monthly injections of bevacizumab for 3 months. During follw up, additional injection was performed if edema was detected...

Read More

9 Months Results of Intravitreal Bevacizumab Injection for the Treatment of Macular Edema Secondary to Branch Retinal Vein Occlusion

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Sun-Taek Lim, Chang-Ryong Kim, Young-Duk Kim, South Korea Background: To evaluate the long-term functional and anatomical effectiveness of intravitreal bevacizumab treatment in eyes with macular edema due to branch retinal vein occlusion (BRVO). Methods: In this retrospective interventional case series, 59 consecutive, previously untreated eyes with macular edema...

Read More

Choroidal Response to Intravitreal Bevacizumab in Macular Edema

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Raimondo Forte, Gilda Cennamo, Elisabetta Chiariello Vecchio, Maria Angelica Breve, Giuseppe de Crecchio, Naples, Italy Advantages: To evaluate choroidal thickness changes in macular edema from different aetiologies after intravitreal bevacizumab. Methods: Prospective, non-randomized, evaluation of 34 eyes (34 patients) with macular edema from different...

Read More

Evaluation of Intravitreal Injection of Triamcinolone Acetonide in Treatment of Macular Edema Secondary to BRVO

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Author: Asaad A. Ghanem, Mansoura, Egypt Advantages: To evaluate the efficacy and safety of intravitreal triamcinolone acetonide (IVTA) for the treatment of macular oedema associated with branch retinal vein occlusion (BRVO). Methods: Thirty-four eyes with macular edema associated with BRVO. Patients were classified into two groups according to the nature of macular...

Read More

Intravitreal Bevacizumab vs Macular Grid Photocoagulation in Non-Ischemic BRVO

http://www.evrs.eu/medias/2009/congress/Retinal-Vein-Occlusions.flv Authors: Isaac Alarcon, Daniel Vilaplana, Vladimir Poposki, Olga Martinez-Giralt, Miguel Castilla, Xenia Acebes, Barcelona, Spain Advantages: Intravitreal Bevacizumab achieves better results in terms of visual acuity in these patients. Methods: Prospective randomized clinical study with 20 patients with non-ischemic BRVO with macular edema. 11 female an 9 male, the mean...

Read More

Macular Demain Branch Retinal Vein Occlusion: Early Treatment Using Laser Arteriolar Constriction Yiels Good Results

http://www.evrs.eu/medias/2009/congress/Which-Laser.flv Authors: Jiri Rehak, Barbora Babkova, Zuzana Pracharova, Martin Sin, Matus Rehak,  Olomouc, Czech Republic Advantages: Determination of prognostically unfavourable branch retinal vein occlusion (BRVO) using initial visual acuity (VA) is a very simple and valuable procedure, which can be done by the general practitioner. The laser arteriolar constriction technique could be successfully...

Read More

Effects of Anti-VEGF Therapy versus Triamcinolone Intravitreal Injection on Non Ischemin Macular Edema of BRVO

Authors: Dong Hyun Jee, Sang Hee Doh, Suwon City, Kyoungki Province, South Korea Advantages: Effects of intrvitreal ranibizumab injection are more efficient than intravitreal triamcinolone injection on non-ischemic macular edema of BRVO. Methods: In a prospective randomised clinical trial, 50 eyes of 50 patients with non-ischemic macular edema of BRVO were included. Eligible eyes were assigned to 0.05mg ranibizumab(25 eyes) or 0.05cc...

Read More

Changes of Aqueous Vascular Endothelial Growth Factor and Pigment Pithelium-Derived Factor Following Intravitreal Bevacizumab for Macular Oedema Secondary to Branch Retinal Vein Occlusion

Authors: Sung Pyo Park, Jae Kyoun Ahn, South Korea Advantages / Purpose: To investigate sequential changes of aqueous vascular endothelial growth factor (VEGF) and pigment epithelium-derived factor (PEDF) in macular oedema secondary to branch retinal vein occlusion (BRVO) following intravitreal injection of bevacizumab (IVB). Methods: We recruited ten healthy controls and forty patients with BRVO. Aqueous levels of VEGF and PEDF were...

Read More

Intravitreal Ranibizumab (Lucentis) for Branch Retinal Vein Occlusion Induced Macular Edema: 6 Months Results of a Prospective Study

Authors: Petros Petrou , Alexander Rouvas, Amalia Ntouraki, Ioannis Ladas, Ioannis Vergados, Athens, Greece Background/Purpose: To evaluate the effect of individualized repeated intravitreal injections of ranibizumab (Lucentis) on visual acuity (VA) and central foveal thickness (CFT) for branch retinal vein occlusion (BRVO)-induced macular edema. Methods: Our study was a prospective interventional case series. 28 eyes of 28 consecutive...

Read More

Forecast of Visual Outcome of Intravitreal Kenalog Injection for Cystoid Macular Edema Caused by Retinal Veins Occlusion using OCT

I.A. Malov, O.A. Ulasevich, K.G. Naumov (State Institution “IRTC Eye Microsurgery” named after S.N. Fyodorov Ekaterinburg Branch, Ekaterinburg, Russia) Advantages: Forecast of visual outcome of intravitreal kenalog injection for cystoid macular edema(CME) caused by retinal veins occlusion using OCT provide a possibility to optimize indications for this procedure. Methods: A retrospective study of 13 patients (13 eyes) with cystoid...

Read More

Favourable Effect of Pars Plana Vitrectomy with Macugen and Lucentis Application as the Treatment of only One Eye with Hemorrhagic Glaucoma due to Central Retinal Vein Occlusion

Dubska, Z., Kalvodova, B., Diblik, P, Klímová, A Advantages: Positive morphological influence of medical treatment with anti-VEGF drugs in combination with PPV pars plana vitrectomy on the only one eye with haemorrhagic glaucoma due to ischemic central retinal vein occlusion CRVO is presented. Methods: Intravitreal injections of Macugen in total 3 times, Lucentis twice, panretinal photocoagulation 1 month after each application, PPV...

Read More

Combined 25g Vitrectomy + Sheathatomy + ILM Peeling + Phacoemulsification + IOL Implantation for the Treatment ofBranch Retinal Vein Occlusion

Murat Oncel, MD (Istanbul, Turkey) SYNOPSIS This film demonstrates the use of the transcon-junctival sutureless 25-gauge vitrectomy system combining with clear corneal phacoemulsification and posterior chamber intraocular lens implantation. Sheathotomy was performed either using a special knife or nitinol flexiable extandible pick with trypan blue-assisted peeling of the internal limiting membrane in branch retinal vein occlusion. Pre- and...

Read More

Central Retinal Vein Occlusion – Anticoagulant Treatment with Warfarin

Jiri Rehak, (Olomouc, Czech Republic), Evzen Fric, MD (Olomouc, Czech Republic), Matus Rehak, MD (Olomouc, Czech Republic), Barbora Babkova, MD (Olomouc, Czech Republic), Zuzana Pracharova, MD (Olomouc, Czech Republic) PURPOSE: It is generally thought that don’t exist effective treatment of central retinal vein occlusion (CRVO). This study evaluate the effect of anticoagulant treatment with warfarin on visual acuity (VA) in the therapy of...

Read More

Intravitreal Triamcinolone for Acute Central Retinal Vein Occlusion: A Randomized Clinical Trial

Alireza Ramezani, MD (Tehran, Iran), S. Morteza Entezari (Tehran, Iran), Siamak Moradian, MD (Tehran, Iran), Homa Tabatabaei, MD (Tehran, Iran), Shohreh Kadkhodaei, MD (Tehran, Iran) PURPOSE: Central retinal vein occlusion (CRVO) is the most common vascular event in the eye after diabetic retinopathy. This study was conducted to evaluate the therapeutic effect and safety of intravitreal triamcinolone acetonide (IVT) in acute...

Read More

Intravitreal Bevacizumab for Idiopathic Central Retinal Vein Occlusion in a 12 Year Old Girl

Jared S. Nielsen, MD (Chicago, IL), Manjot Gill, MD (Chicago, IL) PURPOSE: To describe an unusual case of idiopathic central retinal vein occlusion (CRVO) in a 12 year old girl, and report successful treatment with intravitreal bevacizumab in this pediatric patient. METHODS: Retrospective report of a single case. RESULTS: A healthy 12 year-old white female presented 3 weeks after painless loss of vision in her right eye (Va: CF2FT)....

Read More

Ophthalmic Arterial Fibrinolysis with Urokinase for Recent Severe Central Retinal Venous Occlusion: Initial Experience

Jose Luis Rosales Meneses, MD, PhD (San Cristobal, Venezuela), Jose G. Rosales Meneses, MD (San Cristobal, Venezuela) PURPOSE: To investigate the effects of local ophthalmic arterial fibrinolysis on central retinal venous occlusion (CRVO). METHODS: Ten patients had recent severe nonischemic CRVO for which no alternative therapy was available. A flow-guide microcatheter was introduced coaxially via the femoral artery into the ophthalmic...

Read More

Direct Tissue Plasminogen Activator Infusion Into a Branch Retinal Vein in Patients with Central Retinal Vein Occlusion

Sun-Taek Lim, (Gwangju, South Korea), Young-Duk Kim, MD, PhD (Gwangju, Korea), Chang-Ryong Kim, MD, PhD (Gwangju, Korea), Yeon Lee, MD, PhD (Gwangju, Korea) PURPOSE: To evaluate visual acuity outcomes and retinal blood circulation after direct tissue plasminogen activator (t-PA) infusion into a branch retinal vein. METHODS: In this prospective, non-comparative, casecontrol study, ten eyes of ten consecutive patients with central retinal...

Read More

Unilateral Nonischemic Central Retinal Vein Occlusion in Young Adults

Christos D. Kalogeropoulos, MD (Ioannina, Greece), Maria Stefaniotou (Ioannina, Greece), Ioannis C. Asproudis, MD (Ioannina, Greece), Miltiadis B. Aspiotis, MD (Ioannina, Greece) PURPOSE: Central retinal vein occlusion (CRVO) is relatively rare in young adults. Diagnostic approach was performed in a series of patients with unilateral nonischemic CRVO. The disease outcome was correlated to the final diagnosis and therapy. METHODS: Thirty...

Read More

Transvitreal Radial Optic Neurotomy

Hans Hoerauf, MD (Luebeck, Germany), Philipp Steven, MD (Luebeck, Germany) PURPOSE: The role of radial optic neurotomy (RON) as a new treatment option for central retinal vein occlusion (CRVO) is discussed controversially. To rule out a therapeutic effect of vitrectomy, posterior vitreous detachment (PVD) and/or ILM-delamination a transvitreal RON only was performed in 5 patients. METHODS: In 5 eyes of 5 patients with CRVO (2 ischemic, 3...

Read More

Intravitreal Bevacizumab (Avastin) as Treatment for Macular Edema in Vein Occlusions

Jose Luis Guerrero-Naranjo, MD (Mexico City, Mexico), Hugo Quiroz-Mercado, MD (Mexico City, Mexico), Virgilio Morales- Canton, MD (Mexico City, Mexico), Jans Fromow-Guerra, MD, PhD (Mexico City, Mexico), Griselda Alvarez-Rivera, MD (Mexico City,Mexico), Adriana Solis-Vivanco, MD (Mexico City, Mexico), Elizabeth Reyna-Castelan, MD (Mexico City, Mexico), Maura Abraham, MD (Mexico City, Mexico), Juan Manuel Jimenez-Sierra, MD (Mexico City,...

Read More

Ranibizumab (Lucentis) in Ischemic Central Retinal Vein Occlusion: Interim OCT and Visual Results from the RAVE Trial

Matthew S. Benz, MD (Houston, TX),* David M. Brown, MD (Houston, TX),* Richard H. Fish, MD (Houston, TX),* Rosa Y. Kim, MD (Houston, TX),* Andrew Strickler, MS (Houston, TX), Tien P. Wong, MD (Houston, TX)* PURPOSE: Patients with ischemic central retinal vein occlusion have a high rate of developing anterior segment neovascularization and neovascular glaucoma and often have a dismal visual outcome. The RAVE (Rubeosis Anti-VEGF) study is an...

Read More

Pars Plana Vitrectomy on 23-Year Old Man with Central Retinal Vein Occlusion

Dagmar Dotrelova, MD, PhD (Prague, Czech Republic), Tereza Lainova Vrabcova, MD (Prague, Czech Republic), Jan Kvasnicka, MD (Prague, Czech Republic), Martin Hlozanek, MD (Prague, Czech Republic) PURPOSE: Case report showing complex diagnostics and therapy in young man with central retinal vein occlusion (CRVO). METHODS: CRVO is typically found in population over 60, vascular and hematological disorders are another risk factors. Retinal...

Read More

Intravitreal Bevacizumab for Treatment of Macular Edema in Central and Branch Retinal Vein Occlusion

Ajay Dudani, MD (Mumbai, India), Alay S Banker, MD (Ahmedabad, Gujarat, India), J. Fernando Arevalo, MD, FACS (Caracas, Venezuela) PURPOSE: To report the anatomic and visual acuity response after intravitreal injection of bevacizumab in patients with macular edema due to central retinal vein occlusion (CRVO) and branch retinal vein occlusion (BRVO). METHODS: Prospective study of patients with macular edema due to CRVO/BRVO who were treated...

Read More

New Technique for Acute Central Retinal Vein Occlusion Surgery

http://www.evrs.eu/medias/2006/videos/New-Technique-for-Acute-Central-Retinal-Vein-Occlusion-Surgery.flv Georgiy E. Stolyarenko, MD, PhD (Moscow, Russia) SYNOPSIS New surgical technique of indirect massage of central retinal vein thrombus after acute (4 days) occlusion is shown. Two types of massage – hydrodynamic and mechanical are applied. Two simptomas of passable and unpassable vein are revealed.

Read More

Short Term Visual and Anatomic Outcomes Following Intravitreal Bevacizumab for Macular Edema Secondary to Central Retinal Vein Occlusion

Jose A. Roca, MD (Lima, Peru), Lihteh Wu, MD (San Jose, Costa Rica), Fernando Arevalo, MD (Caracas, Venezuela), Mauricio Maia, MD (São Paulo, Brazil), Maria H. Berrocal, MD (Santurce, PR), Francisco J. Rodriguez, MD (Bogota, Colombia), Michel Eid Farah, MD, PhD (São Paulo, Brazil), Fabio Bom Aggio, MD (São Paulo, Brazil) PURPOSE: To describe the visual and anatomic outcomes of an intravitreal injection of 1.25 mg or 2.5 mg of bevacizumab...

Read More

Particular Profile for Idiopathic Central Retinal Vein Occlusion in Young Adults

Frank J. Becquet, MD, PhD (Nantes, France), Jean-François Le Rouic, MD (Nantes, France), Didier Ducournau, MD (Nantes, France) PURPOSE: To describe and evaluate the prevalence of intensive sport practising among patients with earlyonset central retinal vein occlusion (CRVO). METHODS: Intensive sport practising was evaluated in a consecutive series of 10 patients with CRVO who were younger than 45 years of age (mean age, 37.2 years) from a...

Read More

Pegaptanib Sodium for the Treatment of Macular Edema Following Central Retinal Vein Occlusion

John A. Wells, MD, FACS (Columbia, SC),* PURPOSE: Vascular endothelial growth factor (VEGF) both promotes angiogenesis and enhances vascular permeability. VEGF levels rise following retinal vein occlusion. Selective VEGF blockade has been effective in treating diabetic macular edema. The current trial examined whether this approach was effective in treating macular edema that follows CRVO. METHODS: A randomized, multicenter, double-masked,...

Read More

Radial Optic Neurotomy Plus Intravitreal Triamcinolone with and without Internal Limiting Membrane Peeling for Central Retinal Vein Occlusion

Jose Garcia-Arumi, MD (Barcelona, Spain), Miguel Angel Zapata, MD (Barcelona, Spain), Anna Boixadera, MD (Barcelona, Spain), Alejandro Fonollosa, MD (Barcelona, Spain), Jorge Prieto, MD (Barcelona, Spain), Vicente Martinez-Castillo, MD (Barcelona, Spain) PURPOSE: RON has been proposed to relieve the pressure exerted by scleral ring in CRVO. Vitrectomy, intravitreal triamcinolone and ILM peeling seem to be effective for treating macular...

Read More

Reversal of Ischemic Central Retinal Vein Occlusion: A Novel Technique of Multiple Retinal Vein Decompression and Chorioretinal Venous Anastomosis

Calvin A. Grant, MD (Oak Lawn, IL) PURPOSE: To address the possibility of safe and reproducible multiple sequential branch retinal vein decompression and chorioretinal venous anastomosis for the reversal ischemia central vein occlusion as evidenced by patient satisfaction, vision, pupillary function, and fluorescein and/or ICG angiography. To monitor for neovascularization and vitreous hemorrhage known in laser only CRVA...

Read More

Optical Coherence Tomography Evaluation of Macular Edema after Radial Optic Neurotomy in Patients Affected by Central Retinal Vein Occlusion

http://www.evrs.eu/medias/2005/congress/Optical-Coherence-Tomography-Evaluation-of-Macular-Edema-after-Radial-Optic-Neurotomy-in-Patients-Affected-by-Central-Retinal-Vein-Occlusion.swf F. Patelli, P. Radice, G. Zumbo, F. M. Di Tizio, G. Fasolino, S. Marchi Purpose: To evaluate the characteristics of macular edema (ME) before and after radial optic neurotomy (RON) detected by optical coherence tomography (OCT), in patients with central...

Read More

Comparative Study of Surgical and Conservative Medical Treatment of Vascular Occlusions

Indu Singh, MS Purpose: To compare the results of Vitrectomy with vein decompression (for BRVO) and neurotomy (for CRVO) and conservative management of these diseases with photocoagulation and intraocular injection of Triamcinolone. Methods: 52 eyes with Macular edema and visual acuity worse than 6/24 secondary to BRVO and CRVO were taken up for this study. Four groups were formed wherein the patients underwent either medical or surgical...

Read More

Use of YAG-Laser Retinopuncture for the Treatment of Cystoid Macular Edema (CME) Caused by Thrombosis of Central Retinal Vein and its Branches

http://www.evrs.eu/medias/2005/congress/Use of YAG-Laser Retinopuncture for the Treatment of Cystoid Macular-Edema-(CME)-Caused-by-Thrombosis-of-Central-Retinal-Vein-and-its-Branches.swf Kh. P. Takhchidi, I. A. Malov Purpose: To analyze the results of YAG-laser retinopuncture use for the treatment of cystoid macular edema caused by thrombosis of central retinal vein and its branches. Methods: Eighty patients with cystoid macular edema...

Read More

Macular Edema in Branch Retinal Vein Occlusion (BRVO) – Early Treatment with Laser Arteriolar Constriction Technique. New Approach

http://www.evrs.eu/medias/2005/congress/Macular-Edema-in-Branch-Retinal-Vein-Occlusion-(BRVO)-Early-Treatment-with-Laser-Arteriolar-Constriction-Technique.-New-Approach.swf Jiri Rehak, Barbora Babkova, Zuzana Pracharova, Evzen Fric Department of Ophthalmology, Palacky University, Olomouc, Czech Republic Purpose: To evaluate the effects of laser arteriolar constriction technique in combination with medicamentous therapy on visual acuity (VA)...

Read More

Laser Treatment for Macular Edema

Elisabet Agardh – Ophthalmology, Malmö University Hospital, Sweden Purpose: Macular edema is a major sight-threatening manifestation of retinal vascular disease. Vascular lesions resulting in non-perfusion and hypoxia and subsequent autoregulation of the blood flow, lead to dilation of the arterioles and an increased hydrostatic pressure in the capillaries and venules. The pressure lays an extra burden on the already weakened vessel...

Read More

Different Effect of Intravitreal Triamcinolone Acetonide in the Management of Macular Edema Secondary to Perfusion Type and Ischemic Type Branch Retinal Vein Occlusion

Yun-Sik Yang, Cang-uk Choi, Yong-Woo Kim Purpose: To evaluate the difference of intravitreal triamcinolone acetonide in the management of macular edema secondary to perfusion type and ischemic type branch retinal vein occlusion (BRVO). Methods: 44 patients consecutive patients were selected with a BRVO with macular edema. 23 were perfusion type and twenty one were ischemic type BRVO. These patients received a single intravitreal injection...

Read More

Intravitreal Triamcinolone Acetonide Injection for the Management of Branch Retinal Vein Occlusion

N. Acar, M. Çakır, Y. B. Ünver, Z. Kapran, T. Altan, Z. Bayraktar, E. Y. Pınarcı, I. Perente, M. Dogan Purpose: To evaluate the efficacy of intravitreal triamcinolone acetonide (IVTA) injection for the treatment of macular edema (ME) due to branch retinal vein occlusion (BRVO) by OCT. Methods: In this prospective study, a total 42 eyes of 42 patients with BRVO in which visual acuity is ≤ 0.5 Snellen lines with ME were included in...

Read More

Intravitreal Triamcinolone Acetonide Injection for the Management of Diabetic Macular Edema

http://www.evrs.eu/medias/2005/congress/Intravitreal-Triamcinolone-Acetonide-Injection-for-the-Management-of-Diabetic-Macular-Edema.swf Mehmet Cakir, MD, C. Aslı Utine, MD, Nur Acar, MD, Y. Banu Ünver, MD, Muhammed Beyazal, MD, Irfan Perente, MD, Tugrul Altan, MD, Zerrin Bayraktar, MD, E. Yaman Pınarcı, MD, Ziya Kapran – Beyoglu Eye Research and Education Hospital, Istanbul Purpose: To evaluate the efficacy of intravitreal...

Read More

Internal Limiting Membrane Peeling in Macular Surgery: a Common Physiopathological Mechanism Suggested by Functional Results

http://www.evrs.eu/medias/2005/congress/Internal-Limiting-Membrane-Peeling-in-Macular-Surgery:-a-Common-Physiopathological-Mechanism-Suggested-by-Functional -Results.swf Jean-François Le Rouic, Didier Ducournau, Frank Becquet Purpose: To investigate visual acuity (VA) outcomes after internal limiting membrane (ILM) peeling in macular idiopathic epiretinal membrane (ERM), diabetic macular edema (DME), macular hole (MH), and chronic macular...

Read More

Evaluation of Macular Activity Using mfERG in Patients with BRVO, before and after Sheathetomy

A. Gierek-Lapinska, A. Cywinski, K. Jackiewicz, L. Cwalina Purpose: To evaluate activity of the macula before and after sheathetomy. Methods: 20 patients were operated on 2-3 months after incidence of BRVO. MfERG was performed 1 day before and 1 week, 3 months after the surgery. The results were compared. Results: Improvement of macular activity examined using mfERG were observed in every patient after the surgery. Conclusion: MfERG is an...

Read More

Pathogenesis of Macular Edema in Branch Retinal Vein Occlusion. New Approach.

http://www.evrs.eu/medias/2005/congress/Pathogenesis-of-Macular-Edema-in-Branch-Retinal-Vein-Occlusion.-New Approach.swf Jiri Rehak – Department of Ophthalmology, Palacky University, Olomouc, Czech Republic Purpose: The study of pathogenesis of circulatory disturbances in branch retinal vein occlusion (BRVO) was based on our conviction that better understanding of this problem could be useful in the therapy of this frequent and severe...

Read More
content top